What is Secondary Haemochromatosis

Secondary Haemochromatosis is a condition characterized by an excessive accumulation of iron in the body's tissues, caused by factors other than primary genetic mutations, such as chronic blood transfusions, ineffective red blood cell production, or liver disease. Unlike hereditary forms, Secondary Haemochromatosis is an acquired condition that requires careful management of iron levels to prevent damage to vital organs like the heart, liver, and pancreas.

What causes Secondary Haemochromatosis?

The pathophysiology of Secondary Haemochromatosis stems from an iron overload that exceeds the body’s natural storage capacity. While primary haemochromatosis is caused by genetic defects in iron absorption, Secondary Haemochromatosis is typically triggered by:

• Chronic blood transfusions: Required for conditions like thalassemia or myelodysplastic syndromes.


• Ineffective erythropoiesis: The body’s inability to produce healthy red blood cells, leading to increased iron absorption.


• Chronic liver disease: Including alcoholic liver disease or hepatitis, which alters iron metabolism.


• Excessive oral iron intake: Prolonged, unnecessary supplementation or high dietary iron intake in susceptible individuals.

Which systems are affected by Secondary Haemochromatosis?

When iron levels become toxic, the excess iron deposits in various organs, leading to oxidative stress and tissue damage. The primary systems affected by Secondary Haemochromatosis include the liver (leading to cirrhosis), the heart (causing arrhythmias or heart failure), the pancreas (potentially causing diabetes), and the endocrine system (resulting in hormonal imbalances).

How common is Secondary Haemochromatosis?

The prevalence of Secondary Haemochromatosis is difficult to quantify because it is often a complication of other underlying hematologic or chronic illnesses rather than a standalone diagnosis. While primary genetic haemochromatosis affects roughly 1 in 200 to 500 people of Northern European descent, Secondary Haemochromatosis prevalence is strictly tied to the incidence of the underlying conditions (such as thalassemia major) that necessitate chronic iron loading.

How does it differ from primary haemochromatosis?

The key differentiator is the origin of the iron overload. Primary haemochromatosis is an inherited disorder of iron regulation, whereas Secondary Haemochromatosis is an acquired condition resulting from external iron sources or secondary metabolic dysregulation. Currently, our DiseaseMaps.org community includes 3 members who share their lived experiences with this condition, providing a space for peer support.

Next steps

• Consult a hematologist or hepatologist to monitor ferritin and transferrin saturation levels.


• Discuss iron chelation therapy options with your specialist if you require frequent blood transfusions.


• Join our community at DiseaseMaps.org to connect with others managing iron overload.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult a qualified healthcare professional for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Iron Overload Disorders.


• Orphanet: Rare diseases related to iron metabolism.


• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Hemochromatosis overview.